A large U.S. health records study suggests that difficulty seeing blood in urine may put color-blind patients at higher risk.

A retrospective cohort study suggested that people with color blindness may have a higher risk of mortality from bladder ...

If you have metastatic bladder cancer, you may also be at higher risk for kidney problems, including acute kidney injuries ...

Discover a comprehensive palliative care plan designed to enhance quality of life for those with metastatic bladder cancer.

The American Cancer Society estimates that over 80,000 individuals will be diagnosed with bladder cancer this year.

Overall survival is no better for patients diagnosed with NMIBC who progress directly to metastasis.

ImmunityBio, Inc. (NASDAQ:IBRX) is one of the best penny stocks to buy for 2026. On December 16, ImmunityBio, Inc.

A research team at the Helmholtz-Zentrum Dresden-Rossendorf (HZDR) has developed a radiopharmaceutical molecule marker that ...

When you learn you have bladder cancer, it’s only natural to ask: "Can I survive this, for how long, and can I expect to be cured?" You may have searched online for survival rate information. These ...

ImmunityBio, Inc. (NASDAQ: IBRX), a commercial-stage immunotherapy company, today announced that the Saudi Food and Drug ...

Dr. Soon-Shiong is hopeful the Saudi Arabian FDA's approval of his cancer therapy drug, Anktiva, will lead to widespread ...

What Is Zusduri Used For? Zusduri is used to treat a certain type of recurrent, persistent bladder cancer known as LG-IR-NMIBC. About 75% of people with bladder cancer present with non-muscle invasive ...